SEC Form 4 · accession 0001209191-15-026072
VERTEX PHARMACEUTICALS INC / MA · VRTX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Joshua S Boger
Director
Period of report
Mar 11, 2015
Accepted (ET)
Mar 13, 2015 · 4:30 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000875320
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Mar 11, 2015 | M | 1,300 | $17.16 | A | 373,411 | D | |
| Common Stock | Mar 11, 2015 | M | 10,400 | $35.64 | A | 383,811 | D | |
| Common StockF2,F3 | Mar 11, 2015 | S | 6,200 | $122.56 | D | 377,611 | D | |
| Common StockF3,F4 | Mar 11, 2015 | S | 4,900 | $123.32 | D | 372,711 | D | |
| Common StockF3,F5 | Mar 11, 2015 | S | 600 | $124.12 | D | 372,111 | D | |
| Common StockF6 | holding | — | — | — | 386,284 | D | ||
| Common Stock | holding | — | — | — | 13,286 | I | 401(k) | |
| Common StockF6,F7 | holding | — | — | — | 122,700 | I | Common Stock held in trust |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F8 | $17.16 | Mar 11, 2015 | M | 1,300 | D | — | Jul 19, 2015 | Common Stock | 1,300 | 23,900 | D |
| Stock Option (right to buy)F8 | $35.64 | Mar 11, 2015 | M | 10,400 | D | — | Feb 1, 2016 | Common Stock | 10,400 | 479,200 | D |
Explanation of responses
- F1Transaction made pursuant to Dr. Boger's company approved trading plan under Rule 10b5-1.
- F2Open market sales reported on this line occurred at a weighted average price of $122.56 (range $121.96 to $122.94).
- F3Dr. Boger undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
- F4Open market sales reported on this line occurred at a weighted average price of $123.32 (range $122.97 to $123.78).
- F5Open market sales reported on this line occurred at a weighted average price of $124.12 (range $124.06 to $124.22).
- F6Reflects a change in the form of ownership resulting from a 3/11/2015 distribution of an aggregate of 14,173 shares from grantor retained annuity trusts to Dr. Boger.
- F7Common stock held in grantor retained annuity trusts.
- F8Fully vested.